|Day Low/High||13.54 / 13.95|
|52 Wk Low/High||7.88 / 21.77|
Investors in Fred's Inc. saw new options begin trading this week, for the May 19th expiration.
We are keeping a close eye on the stock, and acting accordingly, until we hear of an official decision on the merger.
Fed's rate hike gives markets a midweek boost. In the portfolio, we trim 1 position and add to 3 others.
As Walgreens Boots Alliance's WBA acquisition of Rite Aid nears FTC approval, Fred's has added several directors with retail experience to its board.
Fred's Inc. (NASDAQ:FRED) today announced that its fourth quarter and full-year 2016 results will be issued on the morning of Thursday, April 6, 2017.
Today's report on the pending merger doesn't adjust our thinking.
Disappointed That the Company Refused to Work in Good Faith With Alden to Reconstitute the Board
Fred's Inc. ("Fred's Pharmacy" or the "Company") (NASDAQ:FRED) today announced that it has appointed Christopher W.
Investors in Fred's Inc. saw new options begin trading this week, for the October 20th expiration.
Fred's Inc. ("Fred's Pharmacy" or "the Company") (NASDAQ:FRED) today reported sales for the four-week fiscal month of February, the first month of fiscal 2017, which ended February 25, 2017.
Looking at the universe of stocks we cover at Dividend Channel, on 2/27/17, Fred's Inc. will trade ex-dividend, for its quarterly dividend of $0.06, payable on 3/15/17.
Here's the latest on this drawn out merger.
Walgreens will now divest up to 1,200 Rite Aid stores to Fred's Pharmacy.
The activist investor could be agitating behind-the-scenes to have Fred's sold after it picks up hundreds of stores required by the FTC to consumate a Walgreen-Rite Aid deal
Fred's, Inc. ("Fred's Pharmacy" or "the Company") (NASDAQ: FRED) today announced that its Board of Directors has declared a quarterly cash dividend of $0.
Billionaire investors appear to see good times ahead with a fellow billionaire in the White House.
David Einhorn's hedge fund, Greenlight Capital, disclosed fresh positions in four stocks.
With nearly $800 million invested in the stock, Apple remains David Einhorn's top investment, but a he's buying up notable positions in some other companies, too.
Einhorn picked up new positions in Syngenta and others.
In recent trading, shares of Fred's Inc. have crossed above the average analyst 12-month target price of $15.50, changing hands for $16.01/share.
Fred's Inc. ("Fred's Pharmacy" or the "Company") (NASDAQ:FRED) today announced three additions to its senior management team.
Fred's Inc. ("Fred's Pharmacy" or "the Company") (NASDAQ: FRED) today reported sales for the four-week fiscal month of January 2017, fourth quarter 2016 and fiscal year 2016 ended January 28, 2017.
Fred's Inc. ("Fred's Pharmacy" or the "Company") (NASDAQ:FRED) today issued the following statement regarding the agreement between Walgreens Boots Alliance, Inc.
Will this deal ever satisfy the FTC? Plus what Jim Cramer thinks.
Investors in Fred's Inc. saw new options become available this week, for the March 17th expiration.
Here are Tuesday's top research calls, including an upgrade for Silgan and downgrades for Apple, Aetna and DineEquity.
Will the merger with Walgreens go through? Investors -- even Jim Cramer -- can't be sure, and that is affecting the drug store stock.
Here's how to trade seven of the most active stocks on the market Monday.